13 March 2020
Visiongain has launched a new pharma report: Global Live Vaccines Market Bacterial, Viral, Oral Polio Vaccine, Measles, Rotavirus, Tuberculosis, Yellow Fever, Oral, Injectable, End Users, Hospitals, Specialty Clinics, Others.
Live attenuated vaccines contain weakened versions of the live virus to create a protective immune response in healthy individuals. They include vaccines for measles, mumps and rubella (MMR), varicella (chickenpox), Oral Polio Vaccine (OPV) etc. The resurgence of interest in vaccine research has been underpinned by the rapidly expanding body of knowledge in the fields of microbial pathogenesis and immunology. This has advanced the ability of researchers and manufacturers to create both preventive and therapeutic vaccines and target new diseases.
The lead analyst of the report commented "There are a number of innovative vaccines in the pipeline, which will enter the market in the coming decade. Advancements in technology will lead to improvements in the efficacy & coverage of vaccines. The recent rise in global disease outbreaks such as Ebola, Zika, Nipah and 1N1 virus has further increased demand for vaccines and galvanised vaccine advocacy. The Asia Pacific region will be the fastest growing submarket, due to a rise in governments implementing national immunisation policies & public awareness initiatives by organisations like WHO."
Leading companies featured in the report include AstraZeneca, Bavarian Nordic A/S, DAIICHI SANKYO COMPANY, LIMITED, Emergent BioSolutions Inc., GlaxoSmithKline plc, Inovio Pharmaceuticals, Inc. & Other Companies.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 207 336 6100.
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
Major investments have been made by companies in the cancer diagnostics industry in the past few years to develop novel tests to capitalize on the opportunities in the untapped market.
19 April 2021
The food for special medical purpose (FSMP) market growth can be attributed to the growing prevalence of metabolic diseases, growing consumer unhealthy lifestyle, and surge in demand from emerging economies such as Asia Pacific, Middle East & Africa, Latin America, and others.
12 April 2021
Growing incidence of chronic diseases; increasing R&D investment for drug discovery research and Growing Adoption of High-Throughput Screening Methodologies are some of the major factors that propel the market growth.
09 April 2021
The main drivers for the growth include technological advancements in the development of novel biomarkers, rising preference for minimally or less invasive surgeries, increasing cancer awareness leading to growth in cancer cases, and growing disposable income in emerging economies.